• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Primary Jejunal Sarcoma Case Demonstrates Rapid Recurrence and Adverse Genetic Alterations

by
November 17, 2026
in Cancer, Health
Reading Time: 3 mins read
0
Primary Jejunal Sarcoma Case Demonstrates Rapid Recurrence and Adverse Genetic Alterations

Primary Jejunal Sarcoma Case Demonstrates Rapid Recurrence and Adverse Genetic Alterations

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a newly published clinical report, authors from Longhui People's Hospital and The Second Xiangya Hospital of Central South University describe an aggressive presentation of primary jejunal follicular dendritic cell sarcoma. Follicular dendritic cell sarcoma represents a rare mesenchymal neoplasm. Jejunal involvement is exceptionally uncommon, accounting for less than 5 percent of all extranodal presentations, with fewer than 20 cases documented in published medical literature. The clinical investigation centers on a 62-year-old female patient who initially sought medical attention after experiencing persistent left lower quadrant abdominal pain.

Diagnostic imaging performed during initial clinical evaluation identified substantial localized disease within the small intestine. A computed tomography scan of the abdomen revealed a jejunal mass measuring 8.7 by 9.4 centimeters. Comprehensive staging assessments identified no radiological enlargement of regional lymph nodes, and no suspicious metastatic lesions were detected within the liver or the spleen. However, because no separate lymph node sampling was undertaken during the initial operative intervention, the pathological nodal status of the malignancy could not be formally assessed or staged.

Pathological evaluation of the resected specimen revealed a large, solid jejunal tumor measuring 13.5 by 9.8 by 7.7 centimeters.

Microscopic and phenotypic evaluation established a definitive diagnosis of classic-type follicular dendritic cell sarcoma based on distinctive cellular morphology and follicular dendritic cell marker immunohistochemistry. The neoplastic tissue showed diffuse positivity for CD21, CD35, CXCL13, and somatostatin receptor 2 (SSTR2), while in situ hybridization for Epstein-Barr virus-encoded small RNA (EBER) was negative. Histopathological examination revealed pronounced adverse features, including geographic tumor necrosis and high proliferative activity characterized by more than 5 mitotic figures per 10 high-power fields.

To further characterize the underlying biological drivers of the malignancy, the medical team conducted targeted next-generation sequencing across both DNA and RNA extracted from tumor tissue. Genomic profiling identified a copy-number loss of the CYLD gene, which functions as a negative regulator of nuclear factor kappa B (NF-κB) activation. In addition, sequencing identified copy-number amplification located on chromosome 15q involving the MAP2K1 gene. This MAP2K1 alteration occurred as a structural copy-number gain in the absence of an activating point mutation. The authors noted that CYLD loss aligns directly with the NF-κB pathway dysregulation previously described in follicular dendritic cell sarcomas.

Targeted sequencing also detected several additional genomic alterations whose direct contributions to tumor development remain unconfirmed. The analysis identified two novel gene fusions, SRSF3::MTCH1 and VIRMA::HOXA13, alongside missense variants within the AXIN1 and CYP2A6 genes, all of which the investigators classified as variants of uncertain clinical significance. Genomic testing also revealed a heterozygous germline pathogenic mutation in the EXT2 gene, which the investigators identified as an incidental finding unrelated to the pathogenesis of the sarcoma. Although these genomic findings provided supportive evidence regarding the biological characteristics of the neoplasm, the authors emphasized that they were supportive rather than independently diagnostic.

Following surgical resection, the patient received adjuvant chemotherapy consisting of the CHOP regimen, combining cyclophosphamide, doxorubicin, vincristine, and prednisone. Despite systemic chemotherapy, the sarcoma exhibited a remarkably rapid recurrence just 3 months after surgical resection, and the patient succumbed to progressive disease 8 months after the initial surgery. The clinical team observed that the exceptionally aggressive clinical course was consistent with the convergence of large initial tumor size, an elevated mitotic index, and adverse genomic copy-number alterations. The authors concluded that cases demonstrating these adverse clinicopathological and molecular features may warrant intensified postoperative disease surveillance and careful consideration of targeted therapies directed against the MEK or NF-κB signaling pathways.

Subject of Research: Clinical, pathological, and genomic characterization of primary jejunal follicular dendritic cell sarcoma.

Article Title: Primary jejunal follicular dendritic cell sarcoma: a case report with clinicopathological, immunophenotypic, and genetic characterization and literature review

Article References: Ning, X., Zhou, M., Xiao, G., Wu, S., Guo, W., Wang, Y., Guo, J., Lei, C., Fan, S., & Ma, X. (2026). Primary jejunal follicular dendritic cell sarcoma: a case report with clinicopathological, immunophenotypic, and genetic characterization and literature review. Frontiers in Oncology, 16, Article 1990004. https://doi.org/10.3389/fonc.2026.1990004

Image Credits: AI Generated

DOI: 10.3389/fonc.2026.1990004

Keywords: follicular dendritic cell sarcoma, jejunal sarcoma, CYLD loss, MAP2K1 amplification, NF-κB pathway, targeted next-generation sequencing, mesenchymal neoplasm, extranodal sarcoma, adjuvant CHOP chemotherapy, CD21 immunohistochemistry, CD35 marker, CXCL13 expression, SSTR2 positivity, geographic necrosis, mitotic rate, SRSF3-MTCH1 fusion, VIRMA-HOXA13 fusion

News Source: Nathaniel Bowman. (November 17, 2026). Primary Jejunal Sarcoma Case Demonstrates Rapid Recurrence and Adverse Genetic Alterations. Scienmag.

Tags: adjuvant CHOP chemotherapyCD21 immunohistochemistryCD35 markerCXCL13 expressionCYLD lossextranodal sarcomafollicular dendritic cell sarcomageographic necrosisjejunal sarcomaMAP2K1 amplificationmesenchymal neoplasmmitotic rateNF-κB pathwaySRSF3-MTCH1 fusionSSTR2 positivitytargeted next-generation sequencingVIRMA-HOXA13 fusion
Share12Tweet7Share2ShareShareShare1

Related Posts

European Rare Disease Guidelines Show Low Methodological Rigor in Scoping Review

European Rare Disease Guidelines Show Low Methodological Rigor in Scoping Review

November 18, 2026
Qualitative Study Identifies Key Supply Chain Barriers During Disasters in Iran

Qualitative Study Identifies Key Supply Chain Barriers During Disasters in Iran

November 18, 2026

Preoperative Strain Predicts Hypertrophy Burden but Not Reverse Remodeling After Valve Replacement

November 18, 2026

HemoCue Hb801 Accurately Measures Hemoglobin While SpHb Tracks Trends

November 18, 2026

POPULAR NEWS

  • Review Identifies Stage-Specific Biological Bottlenecks Limiting Long-Term Cancer Metastasis Control

    Review Identifies Stage-Specific Biological Bottlenecks Limiting Long-Term Cancer Metastasis Control

    29 shares
    Share 12 Tweet 7
  • Lightweight AI Models Enable Reliable Slip Detection on Microcontroller Hardware

    29 shares
    Share 12 Tweet 7
  • Overharvesting Threatens Traditional Cosmetic Plants in South Africa’s Eastern Cape

    29 shares
    Share 12 Tweet 7
  • Distributed Latent Encoding Cuts Cloud Media Retrieval Latency Across Six Datasets

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

European Rare Disease Guidelines Show Low Methodological Rigor in Scoping Review

Study Excludes Magnetically Charged Regular Black Holes in Nonminimally Coupled Theories

Qualitative Study Identifies Key Supply Chain Barriers During Disasters in Iran

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.